CoChat
Sign Up
Cited by 326Nuclear Receptors and SignalingParkinson's Disease Mechanisms and TreatmentsNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 87 of the 89 references it cites were found in a registry or an index.

The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease

Jankovic, J., Chen, S., Le, W.D.·2005·Progress in Neurobiology
DOI 10.1016/j.pneurobio.2005.09.001
Open this paper in CoChat — free account

Abstract

Nurr1, a transcription factor belonging to the orphan nuclear receptor superfamily, is critical in the development and maintenance of the dopaminergic system and as such it may have role in the pathogenesis of Parkinson' disease (PD). Human Nurr1 gene has been mapped to chromosome 2q22-23 and Nurr1 protein is predominantly expressed in central dopaminergic neurons. Nurr1 interacts with other factors critical for the survival of mensencephalic dopaminergic neurons and it appears to regulate the expression of tyrosine hydroxylase (TH), dopamine transporter (DAT), vesicular monoamine transporter 2 (VMAT2), and l-aromatic amino acid decarboxylase (AADC), all of which are important in the synthesis and storage of dopamine. Experimental studies in Nurr1 knock-out mice indicate that Nurr1 deficiency results in impaired dopaminergic function and increased vulnerability of those midbrain dopaminergic neurons that degenerate in PD. Decreased Nurr1 expression is found in the autopsied PD midbrains, particularly in neurons containing Lewy bodies, as well as in peripheral lymphocytes of patients with parkinsonian disorders. Several variants in Nurr1 gene have been reported in association with PD. All these studies suggest that Nurr1 is not only essential in the development of mensencephalic dopaminergic neurons and maintenance of their functions, but it may also play a role in the pathogenesis of PD.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2005.09.001

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 89 references

Research works printed but not linked: 5

  1. Grimes, 2004, A novel mutation in the Nurr1 gene in Parkinson's disease, Mov. Disord., 19, 1120
  2. Jiang, 2004, Effects of ropinirole on progression of parkinsonism in Nurr1 deficient mice and its underlying mechanism, Neurology, 62, A7
  3. Le, 2004, Nurr1 gene targeting therapy for Parkinson's disease, Mov. Dis., 19, S132
  4. Pan, 2005, Reduction of Nurr1 mRNA in human peripheral blood lymphocytes in Parkinson disease, Ann. Neurol.
  5. Pan, 2005, Radicicol induces heat shock protein expression and neuroprotection against rotenone-mediated apoptosis in SH-SY5Y cells, Mov. Dis., S86

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Jankovic, J., Chen, S., & Le, W. D.
Affiliations
  • Baylor College of Medicine (US)
  • Shanghai Jiao Tong University (CN)
Corresponding author
Le, W.D.
ORCID
Venue
Progress in Neurobiology
Publisher
Elsevier BV
Published
2005-09
Volume
77
Issue
1-2
Pages
128-138
ISSN
0301-0082 (ISSN-L)
DOI
10.1016/j.pneurobio.2005.09.001
OpenAlex
W2048841722
Cited by
325
References
89
Citations by year
2026: 10 · 2025: 8 · 2024: 15 · 2023: 14 · 2022: 21 · 2021: 22 · 2020: 13 · 2019: 19 · 2018: 13 · 2017: 19 · 2016: 15 · 2015: 18 · 2014: 16 · 2013: 22 · 2012: 16
FWCI
1.06
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Progress in Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (NS043567, R01NS043567, NS40370, R01NS040370)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
Nurr1, Parkinson's disease, dopaminergic neurons, midbrain, transcription factors, orphan nuclear receptor, tyrosine hydroxylase, dopamine transporter, vesicular monoamine transporter 2, aromatic L-amino acid decarboxylase, Lewy bodies, dopaminergic neuron development, dopaminergic neuron survival
MeSH terms
Animals, Brain, Cell Differentiation, DNA-Binding Proteins, Dopamine, Humans, Neurons, Parkinson Disease, Transcription Factors, Signal Transduction, Nuclear Receptor Subfamily 4, Group A, Member 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review